Skip to content

FACE-Q in Blepharoplasty

Face-Q Patient-Report Assisted Subjective and Objective Evaluation of Upper Eye Lid Blepharoplasty Outcomes Using Different Suturing Techniques: A Randomized Observer and Patient-Blinded Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04924972
Enrollment
90
Registered
2021-06-14
Start date
2019-02-01
Completion date
2022-09-01
Last updated
2022-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatochalasis of Upper Eyelid

Brief summary

The aim of this study is to assess the effect of two different suturing techniques in patients undergoing bilateral upper eyelid blepharoplasty on the results of the FACE-Q Eye Module questionnaire for measuring patient-reported outcomes as well as on the blinded objective assessment by two experienced surgeons using the same questionnaire. We aim to investigate the differences of the 2 most common techniques of skin closure with running cutaneous or subcuticular Nylon (6-0 Prolene) sutures in upper blepharoplasties and their effect on postoperative complications and scar formation. Besides the functional outcomes (visual field) and objective postoperative results, we aim to measure the patients' satisfaction using the FACE-Q Eye Module as a comprehensive, procedure- and disease-specific patient-reported outcome instrument.

Interventions

90 patients undergoing bilateral upper eyelid blepharoplasty are randomly assigned to a suturing technique (running cutaneous or subcuticular Nylon (6-0 Prolene) sutures). Steri-strips will be used until suture removal 7 days after blepharoplasty for patient blinding.

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Women and men between 18-99 years * With bilateral dermatochalasis and resulting visual field restriction * Willingness and ability to comply with regular visits * Signed informed consent form

Exclusion criteria

* Any disease affecting wound closure/healing such as diabetes, connective tissue disease or non-medically induced bleeding disorders, known autoimmune disease, known tendency for hypertrophic scars or keloids; * Untreated hypertension or metabolic syndrome, * Smoker * Asymmetric brow ptosis, * Previous surgery on the eye lids * Sequelae after facial nerve palsy * Allergy or adverse reaction to any substance or material used. * Active or chronic eyelid inflammation Pregnant or breast-feeding women: Women of childbearing potential (18-50) are not excluded form this study. Breastfeeding or pregnant women are however excluded, as bilateral upper eye lid blepharoplasty can be easily postponed.

Design outcomes

Primary

MeasureTime frameDescription
Overall patient satisfaction3 monthsQuestionaire: FACE-Q eye module

Secondary

MeasureTime frameDescription
FACE-Q eye module: individual questions3 monthsQuestionaire: FACE-Q eye module

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026